Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00540_DB01072_nanopub.RARnEnRZvpUy-4crQBC90HUWY-woAw4n_pd_nbz94lhfw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00540_DB01072 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00540_DB01072 label "DDI between Nortriptyline and Atazanavir - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if atazanavir if initiated, discontinued or dose changed. [drugbank_resource:DB00540_DB01072]" assertion.
- drugbank_resource:DB00540_DB01072 identifier "drugbank_resource:DB00540_DB01072" assertion.
- drugbank_resource:DB00540_DB01072 title "DDI between Nortriptyline and Atazanavir - Atazanavir may increase the effect and toxicity of the tricyclic antidepressant, nortriptyline, by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of nortriptyline if atazanavir if initiated, discontinued or dose changed." assertion.
- drugbank:DB00540 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00540_DB01072 assertion.
- drugbank:DB01072 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00540_DB01072 assertion.